Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Undeterred by last year’s rejection and the recent approval of a close rival from Pfizer, Novo Nordisk has pushed its ... which comes in prefilled, premixed pens for subcutaneous injection ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

The insulins available without a prescription come in vials and pens that may need ... teamed up with drugmaker Novo Nordisk to sell its own brand, called ReliOn insulin, which sells for as ...

Since the 1990s, Novo Nordisk has operated a facility in Clayton, where it makes injectable finished products like insulin pens to treat diabetes. In the past few years however, the company has ...

Although no randomized clinical trials using U-500 insulin have been performed, eight case series (involving ... Actrapid U-500, Novo Nordisk in the United Kingdom [voluntarily withdrawn in ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...